Vertex Pharmaceuticals Inc
VRTXLatest QuantConomy context for VRTX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Vertex Pharmaceuticals Inc
QuantConomy has a structured record for VRTX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- VRTX
- Name
- Vertex Pharmaceuticals Inc
- Coverage
- 3 market/data records
- Sources
- alpaca alphavantage fmp lse
Recent signals for VRTX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| large accumulation | very bullish | 73 | Jul 8, 01:30 PM | Assenagon Asset Management S.A. increased position in 0A8026 by 41.4% - 759,564 shares ($377.30M) - [strong very bullish signal] |
| large accumulation | very bullish | 80 | Jul 8, 12:17 PM | WELLS FARGO & COMPANY/MN increased position in 0A8026 by 489.9% - 447,030 shares ($199.62M) - [very strong very bullish signal] |
| increased position | very bullish | 74 | Jul 8, 12:17 PM | WELLS FARGO & COMPANY/MN increased position in 0A8026 by 72.4% - 130,688 shares ($58.36M) - [strong very bullish signal] |
INSTITUTIONAL signals are experimental: historical 13F coverage is still being backfilled, so results may be sparse or empty.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| VRTX | NASDAQ | alpaca | Vertex Pharmaceuticals Incorporated Common Stock |
| VRTX | NASDAQ | alphavantage | Vertex Pharmaceuticals Inc |
| VRTX | NASDAQ | fmp | Vertex Pharmaceuticals Incorporated |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | sale | 1,541 | $519.00 | $799,779 | 4 on EDGAR |
| Jul 2, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | sale | 1,500 | $524.99 | $787,485 | 4 on EDGAR |
| Jul 1, 2026 | Liu Joy | EVP and Chief Legal Officer | sale | 828 | $502.71 | $416,244 | 4 on EDGAR |
| Jun 26, 2026 | Bozic Carmen | EVP and CMO | sale | 596 | $482.50 | $287,570 | 4 on EDGAR |
| Jun 18, 2026 | Bozic Carmen | EVP and CMO | sale | 1,020 | $462.17 | $471,413 | 4 on EDGAR |
| Jun 5, 2026 | Bozic Carmen | EVP and CMO | sale | 1,745 | $450.00 | $785,250 | 4 on EDGAR |
| Jun 1, 2026 | Liu Joy | EVP and Chief Legal Officer | sale | 828 | $439.91 | $364,245 | 4 on EDGAR |
| May 29, 2026 | Bozic Carmen | EVP and CMO | sale | 1,974 | $450.00 | $888,300 | 4 on EDGAR |
| May 15, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | sale | 33 | $453.45 | $14,964 | 4 on EDGAR |
| May 15, 2026 | Bozic Carmen | EVP and CMO | sale | 1,354 | $453.45 | $613,971 | 4 on EDGAR |
| May 12, 2026 | Bozic Carmen | EVP and CMO | sale | 6,988 | $450.00 | $3,144,600 | 4 on EDGAR |
| May 1, 2026 | SACHS BRUCE I | Insider | grant | 2,866 | — | — | 4 on EDGAR |
| May 1, 2026 | Bhatia Sangeeta N. | Insider | grant | 943 | $0.00 | $0 | 4 on EDGAR |
| May 1, 2026 | MCKENZIE DIANA | Insider | grant | 943 | $0.00 | $0 | 4 on EDGAR |
| May 1, 2026 | Thornberry Nancy | Insider | grant | 472 | $0.00 | $0 | 4 on EDGAR |
| May 1, 2026 | Garber Alan M | Insider | grant | 472 | $0.00 | $0 | 4 on EDGAR |
| May 1, 2026 | Lagarde Michel | Insider | grant | 2,866 | — | — | 4 on EDGAR |
| May 1, 2026 | Schneider Jennifer | Insider | grant | 472 | $0.00 | $0 | 4 on EDGAR |
| May 1, 2026 | Liu Joy | EVP and Chief Legal Officer | sale | 1,104 | $425.02 | $469,222 | 4 on EDGAR |
| May 1, 2026 | CARNEY LLOYD | Insider | grant | 2,866 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query VRTX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access